Modernizing FDA regulations to advance a value-driven health care system

A modern regulatory framework is the foundation of an innovative health care system that allows stakeholders to work together to deliver better outcomes for patients. To advance critical regulations toward this end, the U.S. Food and Drug Administration (FDA) announced last September that it would engage in a comprehensive review of its rules governing biopharmaceutical company communications related to unapproved uses of approved medicines. The FDA also sought input on this from key stakeholders over a two-day public hearing late last fall.
Source: The Catalyst - Category: Pharmaceuticals Tags: Value-Driven Health Care GoBoldly Source Type: news